Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MindWalk Holdings Corp. (HYFT : NSDQ)

• Company Description    MindWalk is a Bio-Native AI company transforming drug discovery and development. MindWalk, formerly known as ImmunoPrecise Antibodies Ltd., is based in AUSTIN, Texas. Number of Employees: 77

• Price / Volume Information    Yesterday's Closing Price: $1.31 Daily Weekly Monthly 20 Day Moving Average: 145,292 shares Shares Outstanding: 46.71 (millions) Market Capitalization: $61.19 (millions) Beta: 0.82 52 Week High: $2.99 52 Week Low: $0.99 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.38% -4.34% 12 Week -13.82% -16.98% Year To Date -28.02% -35.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Industrious 823 Congress Ave Suite 300 - Austin,TX 78701 USA ph: 1-800-620-4187 fax: - investors@mindwalkai.com http://www.mindwalkai.com

• General Corporate Information    Officers Jennifer Bath - Chief Executive Officer; President and Director Dirk Witters - Chairman R. Scott Areglado - Chief Financial Officer Kari Graber - Vice President of Commercial Services Jon Lieber - Director Peer Information MindWalk Holdings Corp. (EVOL) MindWalk Holdings Corp. (RAMP) MindWalk Holdings Corp. (EFOR) MindWalk Holdings Corp. (LGTY) MindWalk Holdings Corp. (ALOT) MindWalk Holdings Corp. (CXT) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 602687105 SIC: 2834 Fiscal Year Fiscal Year End: April Last Reported Quarter: 07/01/26 Next Expected EPS Date: 12/21/26 Share - Related Items Shares Outstanding: 46.71 Most Recent Split Date: (:1) Beta: 0.82 Market Capitalization: $61.19 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.21 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 12.36 Price/Cash Flow: - Price / Sales: 5.23 EPS Growth vs. Year Ago Period: -28.57% vs. Previous Quarter: -50.00% Sales Growth vs. Year Ago Period: 20.22% vs. Previous Quarter: -7.60% ROE 07/31/26 - -133.26 04/30/26 - -92.61 01/31/26 - -69.37 ROA 07/31/26 - -77.78 04/30/26 - -54.15 01/31/26 - -39.74 Current Ratio 07/31/26 - 1.84 04/30/26 - 2.80 01/31/26 - 3.74 Quick Ratio 07/31/26 - - 04/30/26 - 2.72 01/31/26 - 3.64 Operating Margin 07/31/26 - -105.25 04/30/26 - -97.07 01/31/26 - -73.12 Net Margin 07/31/26 - -105.11 04/30/26 - -89.65 01/31/26 - -66.79 Pre-Tax Margin 07/31/26 - -106.69 04/30/26 - -99.96 01/31/26 - -74.38 Book Value 07/31/26 - 0.11 04/30/26 - 0.18 01/31/26 - 0.23 Inventory Turnover 07/31/26 - 12.00 04/30/26 - 12.60 01/31/26 - 7.99 Debt-to-Equity 07/31/26 - 0.43 04/30/26 - 0.26 01/31/26 - 0.21 Debt-to-Capital 07/31/26 - 30.27 04/30/26 - 20.71 01/31/26 - 17.25

Powered by Zacks Investment Research ©